Dosage form modification and oral drug delivery in older people by Lau, Esther T. L. et al.
Accepted Manuscript
Dosage form modification and oral drug delivery in older people
Esther T.L. Lau, Kathryn J. Steadman, Julie A.Y. Cichero, Lisa M.
Nissen
PII: S0169-409X(18)30064-4
DOI: doi:10.1016/j.addr.2018.04.012
Reference: ADR 13293
To appear in: Advanced Drug Delivery Reviews
Received date: 3 July 2017
Revised date: 15 February 2018
Accepted date: 12 April 2018
Please cite this article as: Esther T.L. Lau, Kathryn J. Steadman, Julie A.Y. Cichero, Lisa
M. Nissen , Dosage form modification and oral drug delivery in older people. The address
for the corresponding author was captured as affiliation for all authors. Please check if
appropriate. Adr(2018), doi:10.1016/j.addr.2018.04.012
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
1 
 
Dosage form modification and oral drug delivery in older people 
Esther T.L. Laua, Kathryn J. Steadmanb, Julie A.Y. Cicherob, Lisa M. Nissena* 
*Corresponding author 
a. School of Clinical Sciences, QUT (Queensland University of Technology), Gardens 
Point Campus, 2 George St, Brisbane, Qld, Australia, 4000; et.lau@qut.edu.au and 
l.nissen@qut.edu.au  
b. School of Pharmacy, University of Queensland, Pharmacy Australia Centre of 
Excellence, 20 Cornwall St, Woolloongabba, Qld, Australia, 4102; 
k.steadman@uq.edu.au and j.cichero@uq.edu.au  
 
Abstract 
Many people cannot swallow whole tablets and capsules. The cause ranges from 
difficulties overriding the natural instinct to chew solids / foodstuff before swallowing, 
to a complex disorder of swallowing function affecting the ability to manage all food 
and fluid intake. Older people can experience swallowing difficulties because of co-
morbidities, age-related physiological changes, and polypharmacy. To make 
medicines easier to swallow, many people will modify the medication dosage form 
e.g. split or crush tablets, and open capsules. Some of the challenges associated 
with administering medicines to older people, and issues with dosage form 
modification will be reviewed. Novel dosage forms in development are promising and 
may help overcome some of the issues. However, until these are more readily 
available, effective interdisciplinary teams, and improving patient health literacy will 
help reduce the risk of medication misadventures in older people. 
Graphical abstract 
Keywords: solid oral dosage forms, crushing tablets, opening capsules, dosage-form 
modification, polypharmacy, swallowing difficulties, health literacy, dysphagia 
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1 Why is swallowing pills so difficult for some people? 
Solid oral dosage forms e.g. pills, tablets, capsules are excellent drug delivery 
systems as they are often cheap to manufacture, and conveniently deliver medicines 
into the body – but only if people can swallow them. There is an enormous array of 
solid oral dosage forms in use, or undergoing research and development. However, 
many people, regardless of age, have trouble with swallowing solid oral medication 
dosage forms whole [1]. 
Swallowing solid oral medications whole, without chewing, is a learned skill [1]. 
Children are taught to chew food properly before they swallow it. Chewing reduces 
the particle size of foodstuff, mixes food particles with salivary enzymes to begin 
chemical digestion, and forms a bolus that can be safely swallowed without being 
aspirated. The gag reflex is a protective mechanism to eject anything too big to be 
safely swallowed. Therefore, people are both hardwired and trained to chew even 
the smallest of foods e.g. a raisin, and swallowing hard substances without chewing 
involves overriding this natural reflex [2, 3]. For instance, people expect to chew a 
cashew nut before swallowing it. Therefore, asking patients to swallow, without 
chewing a whole tablet or capsule, which in many cases may be bigger than a 
cashew nut, can be challenging (Figure 1). 
A previous bad experience with swallowing a solid dosage form can lead some 
people to modify some or all of their medication dosage forms [4]. This practice may 
also have been behaviour learnt from parents or relatives as a child, or children may 
never have been explicitly taught, or learned how to swallow solid dosage forms [1]. 
Solid oral dosage forms vary in sizes, shapes and colours, and there is a preference 
for those that are small, coated, arched, oblong/oval in shape and white in colour [5]. 
Nevertheless, solid oral dosage forms of various sizes and shapes can be 
swallowed. Not unexpectedly, perception is important, as in a recent study, 23% of 
152 adults who reported no difficulty swallowing foods or drinks, visually assessed a 
size 00 capsule as being “too large to swallow whole”. Yet only 3% were physically 
unable to accomplish the task when asked to swallow a 00 capsule with water [6]. 
As many as 50-60% of older people in hospitals and aged care facilities experience 
impaired swallowing function (dysphagia). Swallowing food and fluids is difficult for 
these people, and there is an increased risk of choking or aspiration [7-9]. Carers for 
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people living with dysphagia may primarily be concerned about maintaining 
adequate nutrition and hydration. However, people’s ability to take oral medications 
is an important problem that needs to be considered at the point of dosage form 
design, prescribing and dispensing. Unfortunately, this consideration is often 
overlooked, and the person administering the medication is usually left to find a way 
to help the patient swallow their medications [10, 11]. 
2 Prevalence of pill swallowing difficulties 
It is challenging to estimate the proportion of people that find it difficult to swallow 
solid oral dosage forms because the methodology and the population being 
investigated varies between research studies. Reports indicate between 10% and 
40% of adults have difficulties swallowing solid oral medications (Table 1). There is 
more data available regarding the prevalence of dysphagia (Table 2), particularly 
among older people.   
Table 1. Studies reporting the prevalence of people having experienced problems 
swallowing whole solid medications at some time. Age range and mean ± SD of respondents 
is provided in parentheses, and details specific to the older population are provided where it 
was described or could be extracted from the article. 
Country and setting Total number of 
respondents 
Problems swallowing whole solid 
dose forms 
  Proportion of total 
respondents 
Proportion of 
older 
respondents 
Germany [4]; general 
practice patients taking at 
least one solid oral dose 
form, questionnaire 
1051 adults  
(18 – 80+; 61.8 ± 
15.6 years) 
37.4% 
 
27%  
(≥ 70 years) 
US [12]; adults, online 
survey 
679 adults 
(18 – 65+ years) 
40% 
 
26% 
(≥ 65 years) 
Australia [13]; customers of 
community pharmacies, 
interview 
369 adults 
(18 – 60+ years) 
16.5%  
 
14.7% 
(≥ 60 years) 
Switzerland [14]; customers 
of community pharmacies 
taking 3 or more solid oral 
dose forms, interview 
410 adults 
(19 – 96; 66.5 ± 
14.8 years) 
22.4% 
 
- 
Norway [15]; general 
practice patients; 
questionnaire 
6158 adults 
(1 – 70+ years)  
26% 
 
- 
Jordan [16]; outpatients 
taking at least one oral solid 
dose form, interviews 
1250 adults 
(18 – 90 years) 
10.4% 
 
- 
UK [17]; community 
pharmacy customers taking 
156 adults  
(≥ 65; 74 ± 5.7 
n/a 7.8% 
(≥ 65 years) 
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at least one oral medicine, 
interview 
years) 
New Zealand [18]; 
community-dwelling, taking 
at least one prescription 
medicine, telephone 
interview 
316 adults  
(75 – 98 years) 
n/a 14% 
(≥ 75 years) 
Belgium [19]; community 
pharmacy customers using 
at least one chronic 
medicine, cross-sectional 
observational study 
338 adults  
(70 – 90+ years) 
n/a 14.8% 
(≥ 70 years) 
 
Table 2. Examples of studies reporting the prevalence of dysphagia amongst people living at 
home in the community, in aged care facilities, or admitted to geriatric units in hospital. Age 
range and mean ± SD of respondents is provided in parentheses, and details specific to the 
older population (and age criteria) are provided where it was described or could be extracted 
from the article. 
Country and setting Total number of 
respondents 
Dysphagia 
Proportion of total 
respondents 
Proportion of older 
respondents 
In the community 
UK [17]; community 
pharmacy 
customers taking at 
least one oral 
medicine, interview 
156 adults  
(≥ 65; 74 ± 5.7 
years) 
n/a 11% 
 
UK [20]; otherwise 
healthy, living in the 
community, 
questionnaire 
634 adults 
(69 – 98 years) 
n/a 11.4% 
 
Japan [21]; living at 
home in the 
community, 
questionnaire 
1313 adults  
(≥ 65 years)  
n/a 13.8% 
 
Netherlands [22]; 
living in the 
community, 
interview 
130 adults  
(87 – 95; 89.6 ± 2.3 
years) 
n/a 16% 
 
Netherlands [23]; 
general population 
in the community, 
telephone survey 
2600 adults 
(18 – 97 years) 
12.1% 16.3% 
(> 60 years) 
USA [24]; general 
practice patients, 
questionnaire 
947 adults 
(46.2 ± 16.2 years) 
22.6% 
 
- 
USA [25]; 
independent-living 
community 
residents, 
questionnaire 
107 adults 
(≥ 65; 75 ± 6 years) 
n/a 15.9% 
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In aged care facilities 
South Korea [26]; 
residents of aged 
care facilities, 
observation 
395 adults  
(65 – 103; 80.8 ± 8.0 
years) 
n/a 52.7% 
 
Canada [27]; 
residents of aged 
care facilities, 
observation 
349 adults 
(71 – 108 years) 
n/a 68%  
 
UK [28]; residents of 
aged care facilities, 
prior clinical 
diagnosis 
166 adults  
(> 70 years) 
n/a 22.9% 
 
Admissions to hospital geriatric units 
Spain [8]; 
admissions with 
pneumonia, clinical 
assessment 
134 adults 
(84.5 ± 6.8 years) 
n/a 55% 
Belgium [29]; 
admissions to 
geriatric units, 
clinical assessment 
1262 adults n/a 43% 
 
Dysphagia becomes more common with increasing age [23, 24], so it is tempting to 
expect that medication swallowing problems also become more common. However, 
where a wide age range has been surveyed, a lower proportion of older people 
report difficulty swallowing tablets compared with younger people [4, 12, 13, 15]. 
This has been suggested to be associated with differences in physiological and 
anatomical differences in the size and function of the oral and oesophageal regions 
[4]. Additionally, medicine use tends to increase with age, so it is possible that 
people become more adept at swallowing these dosage forms with practice. 
However, older people with dysphagia are likely to be under-represented in studies 
focussed on community-based individuals that survey the healthier, ambulatory 
members of the population who attend their GP rooms, collect their own medicines 
from the pharmacy or are willing and capable of completing surveys [4, 13]. Indeed, 
up to 68% of residents of aged care facilities have been reported to exhibit 
symptoms of dysphagia, which is considerably higher than amongst older people 
living in the community (Table 2).  
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3 Age related changes to physiological processes of swallowing 
The act of swallowing requires coordination between sensorimotor and 
neuromuscular processes to ensure foods and liquids follow the intended 
gastrointestinal route to the oesophagus, and do not ‘go down the wrong way’ into 
the airways. Older people, as a natural part of the ageing process, take longer to 
swallow because more time is required for chewing and bolus manipulation. A 
generalised decrease in all muscle mass and muscle strength, including those in the 
mouth and throat potentially reduces swallowing effectiveness. This can be 
compounded by reduced sensations of residue collecting in the throat, along with 
ageing-related postural changes affecting head position, which increase the risk of 
aspiration. Further changes to the oesophagus may ensue, reducing the efficiency of 
bolus movement into the stomach. This is known as presbyphagia, the natural 
changes in healthy swallowing that put older people at risk of developing dysphagia 
[9, 30]. For the most part, healthy older adults can compensate to maintain 
coordination and effective swallowing, albeit more slowly than in their youth. The 
maintenance of disease-free presbyphagia is important for safeguarding good health 
in older people.  
Decline into medically-recognised dysphagia is commonly associated with the 
development of co-morbidities, or stresses such as changes in dentition [9, 31]. 
Swallowing is a very complex process, and conditions that disrupt the central 
coordination of swallowing, such as stroke, Parkinson’s disease, or head injury, often 
lead to dysphagia. Changes at a structural level, through malignancies and other 
diseases of the throat, affect swallowing function, as can radiation therapy to the 
head and neck region, and inflammatory disorders such as Crohn’s disease [9, 31]. 
The development of xerostomia (dry mouth), for example through an autoimmune 
disease such as Sjogren’s syndrome affecting salivary output, can play a key role in 
the decline into dysphagia. Saliva lubricates solid oral dosage forms, preventing 
them from sticking to the throat or oesophagus, so xerostomia can contribute to 
problems with swallowing medicines. 
Medications are themselves a major contribution to the development of dysphagia, 
through their role in causing dry mouth, and other adverse drug reactions that can 
impact upon ability to swallow. Examples of adverse drug reactions are the reduced 
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muscle coordination of the mouth, throat and oesophagus (e.g. phenothiazines and 
haloperidol, and heavily sedated patients), and direct injury such as ulceration or 
irritation of the mucous membranes and oesophagus (e.g. cytotoxics, non-steroidal 
anti-inflammatory drugs, tetracyclines, bisphosphonates). Xerostomia is a particularly 
important side effect, since an estimated 80% of the most commonly prescribed 
medicines cause xerostomia [32]. As saliva production is largely regulated by the 
parasympathetic nervous system, medicines with strong anticholinergic properties, 
i.e. antipsychotics, antidepressants, antihistamines, are widely recognised as having 
xerostomia as a side effect. For older people, anticholinergic burden or load needs to 
be considered. That is, the cumulative effects of taking a number of medicines with 
weak anticholinergic effects, e.g. anticonvulsants, analgesics, blood pressure 
agents, diuretics, can be as significant as a single highly anticholinergic agent [33]. 
Older adults are commonly prescribed multiple concurrent medications to manage 
multiple comorbidities. Polypharmacy (being prescribed five or more medicines) is 
itself associated with negative clinical outcomes for patients e.g. increased burden of 
disease, medication misadventures and adverse drug events, hospitalisation and 
increased mortality [34]. 
The problems associated with being unable to safely or effectively swallow solid oral 
dosage forms is compounded if the medicines require multiple doses each day. As 
such, a vicious cycle is propagated in which co-morbidities may not be adequately or 
appropriately managed because the patient cannot swallow the solid oral dosage 
forms, and in turn, more medicines may be prescribed to help manage the 
deteriorating patient. 
4 Options for people who cannot swallow solid oral dosage forms  
When people experience difficulty swallowing their solid oral dosage forms whole 
without chewing, they may choose to avoid taking the medication, or implement 
strategies to make the medicine easier to swallow [4, 12-14, 16]. While these 
strategies are not unique to older people, they are very relevant in discussions 
around administering medicines to this patient cohort. Clinical guidelines can provide 
recommendations for administering medicines to people unable to swallow solid oral 
medicines. However, strategies that patients or carers use may be in direct contrast 
to clinical expert recommendations, e.g. the modification of medication dosage 
forms, which will be discussed in Section 5.  
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Patients clinically diagnosed with dysphagia are generally expected to have 
difficulties swallowing both solids and liquids. Therefore swallowing solid oral dosage 
forms, and potentially liquid dosage forms, becomes challenging and may need to be 
avoided due to the risk of aspiration [35, 36]. It has been estimated that up to 7% of 
foreign bodies aspirated into the airways are medications [37], e.g. iron pills, 
tetracycline tablets, sucralfate, and sometimes with fatal results [37-40]. Aspiration of 
tablets or capsules is challenging to diagnose as the foreign body may not have 
been recognised as an aspiration event at the time, may not be identified as a 
foreign body on x-ray as the medication is not radiolucent, or may have dissolved. 
Extra care should be taken when administering medication to people where 
swallowing coordination, or protective cough and gag reflexes are affected [41], and 
these patients should be observed for signs of potential aspiration [42]. 
4.1 Alternative commercially manufactured dosage forms 
An option to bypass the use of a solid oral dosage form is to seek an alternate 
commercially available dosage form of the medicine, such as a dispersible or 
effervescent tablet, change to a different route of administration or consider a 
different medicine within the same therapeutic class that is commercially available as 
an appropriate dosage form. Clearly this has cost implications, and the majority of 
the medicines are only available in limited delivery formats. Interestingly, even when 
more clinically appropriate alternatives are available, apparently patients, carers, and 
healthcare professionals continue to modify medication dosage forms [43-46], based 
on the perception that non-coated, non-modified-release tablets are safe to cut and 
crush. 
Some commercially available dosage forms that can be alternatives to traditional 
solid oral dosage forms include [47]:- 
 Non-solid oral dosage forms e.g. concentrates, elixirs, emulsions, films 
(extended release), solutions, suspension (delayed and extended release), 
granules (delayed release), chewing gum, liquids, oils and drops, pellets, 
powder (extended release), solutions, suspensions (extended release), 
syrups. 
 Non-traditional solid oral dosage forms that do not need to be swallowed 
whole e.g. tablets that are chewable, effervescent, dispersible, oral 
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disintegrating, oral disintegrating extended release; oral disintegrating delayed 
release; troches and lozenges. 
 Parenteral dosage forms e.g. metered aerosols, enemas, implants, injections 
(lipid complex, liposomal, extended release), patches, dry powder inhalers, 
metered solutions, metered sprays, suppositories. 
However, many of the non-solid oral dosage forms are only available as paediatric 
formulations. Similarly, there is a very limited number of medicines that are 
formulated as non-traditional solid oral dosage forms because of complexities and 
cost to manufacture. Furthermore, oral liquids, or solid oral dosage forms are an 
aspiration risk for people with dysphagia. Parenteral dosage forms are also limited in 
their usefulness because many medicines are available via the oral route only. 
Additionally, trained personnel are required to administer some of the dosage forms 
e.g. injections, implants, and there are challenges with drug absorption and 
formulation because of the characteristics of the medicine e.g. hydrophilic drugs 
cannot easily be absorbed transdermally via a patch; or pulmonary delivery via 
inhalers. Inhalers also have the added concern around incorrect inhaler techniques, 
and whether older people have the manual dexterity to use the devices. Finally, 
some of the parenteral dosage forms would be restrictive and inconvenient for the 
patient to self-administer particularly if they need a large number of medicines 
concurrently, or with repeated dosing e.g. suppositories, enemas. 
4.2 Extemporaneously compound medicines into an appropriate dosage form. 
Extemporaneous compounding is the preparation of a therapeutic product for an 
individual patient in response to an identified need, e.g. inability to swallow 
commercially available dosage forms. Compounded preparations have generally not 
been assessed for safety and efficacy. Their use is off label and is based on 
extrapolation from the component ingredients [48]. In clinical practice, patients do not 
seek extemporaneous compounding as an option for overcoming difficulties with 
swallowing solid oral medicines. This is possibly because of lack of awareness of 
compounding as an option, or logistics and cost of sourcing these products may be 
prohibitive for many patients. For example, in Australia, many of the compounded 
medicines are not government subsidised, meaning patients need to cover the entire 
cost of the medicine out of their own pocket. 
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The raw material of the active pharmaceutical should ideally be sourced for 
extemporaneous compounding but sometimes this is not realistic or achievable. As 
such, crushed tablets or the contents of capsules are often used as the source of the 
active ingredient for extemporaneous compounding of oral liquid formulations by a 
pharmacist [49]. The presence of insoluble excipients in the commercial solid dosage 
form usually means the formulation must be a suspension. The formulation for these 
suspensions can be complex to design, requiring consideration of powder wetting, 
vehicle viscosity, preservation and flavouring [50]. Additionally, the length of time a 
compounded version retains its chemical and physical characteristics is usually 
unknown, and interactions between the active ingredient and excipients from the 
original solid dosage form can be more important than degradation by standard 
routes such as oxidation and hydrolysis [51]. Thus, extemporaneous preparations 
invariably have short expiry dates, though this is usually through lack of information 
on the preparation than a reflection of true stability [48]. 
4.3 Removing unnecessary medicines. 
Older people may be taking medicines for years on end for no particular reason, 
because no-one told them to stop the medication. Optimising medication therapy, 
and ceasing medicines that are no longer necessary can reduce the pill burden on 
patients [34]. Reducing polypharmacy can also reduce the risk of side effects that 
may contribute to a patient’s ability to swallow (section 3). 
5 Modifying solid oral dosage forms  
Many patients and carers will modify solid oral dosage forms to make medicines 
easier to swallow [43-46].  Dosage form modification can be as simple as chewing a 
tablet before it is swallowed. Capsules can be opened, and tablets may be split by 
hand or a sharp kitchen knife, or crushed between two spoons, or with a pestle and 
mortar. An array of splitting and crushing devices are also commercially available.  
5.1 Dangers of modifying solid oral dosage forms  
Regardless of the motivation and intention behind these practices, there are inherent 
risks and dangers associated with modifying solid oral dosage forms (Table 3). A 
recognition of the potential problems associated with modifying, then administering a 
dosage form, have led to development of resources that provide guidance on these 
practices [42, 52]. Although these resources are commonly prepared with the 
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regulatory situation of a specific country in mind, the clinical information is generally 
widely applicable across different jurisdictions. The importance of not altering dosage 
forms that are designed to have modified release properties is fairly well recognised 
amongst health professionals, as the consequences can be severe [42, 53, 54]. 
Reduced dose delivery through loss during crushing and transfer is less commonly a 
consideration, as spills and residual powder along with sharing of crushing vessels 
are often seen during observational research [44, 45, 55-57]. In fact, at least 5-10% 
of every dose, and probably more than that, is not delivered to the patient [58-60]. 
Rinsing the crushing vessel with water, and consuming that water can significantly 
reduce drug loss [58, 61] but this is not an approach commonly observed in practice. 
Additionally, as water may pose safety challenges for patients with dysphagia, 
standard clinical practice is to pour the powder out of the crushing device into 
another receptacle containing the food or thickened fluid (Section 6.1). Unless the 
food or fluid is completely consumed and the vessel is licked clean, it is unlikely the 
entire dose will be ingested. Therefore, drug loss and variability in dose delivery 
across the whole administration process needs further exploration.  
Table 3. Potential problems associated with modifying solid dosage forms 
Problem Outcome 
Altered efficacy and adverse effects 
 Destruction of modified-release 
characteristics. 
 Rate and extent of drug dissolution and 
absorption increases. 
 Increased risk of fluctuations to supra-
optimal and sub-therapeutic blood levels.  
 Patients have died as a result of taking 
crushed modified-release dosage forms 
[42, 53, 54]. 
Destruction of coatings designed to 
protect the medication from the 
patient, or protect the patient from 
the medication (e.g. enteric coatings 
and the stomach). 
 Reduced efficacy through sub-therapeutic 
blood levels when drug is degraded in the 
stomach. 
 Adverse events due to medication irritating 
the stomach. 
Inaccurate dosing 
 Powder loss during crushing and 
transfer e.g. spilled or left behind in 
vessel [44, 45, 55, 57]. 
Estimates: from 3-13% loss using a 
mortar & pestle [58, 59], to 30% loss 
with an electric grinder [60]. 
 Incomplete dosing and/or inconsistent 
dosing of medicines. 
 Can be clinically significant e.g. thyroxine 
delivered by a feeding tube led to a 
hypothyroid state due to loss during 
crushing and transfer [57]. 
 Particular concern for vulnerable patients, 
or medicines with a narrow therapeutic 
window. 
Incorrect administration 
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 Sharing of crushing devices without 
cleaning [44, 45, 55-57]. 
 Risk of cross-contamination. 
Mixing with meals or drinks.  Risk of administration to wrong person. 
 Concerns also arise if people do not finish 
consuming the entire meal or drink.  
Incorrect route of administration.  Risk of nursing staff mistaking oral 
syringes/dispensers for IV syringes. 
 Fatalities have occurred because oral 
medicines have been injected 
intravenously [42, 62]. 
Delivery of crushed powder directly 
into enteral feeding tubes. 
 Clogged feeding tubes. 
 Needs to be reduced to a fine powder and 
dispersed in water, and then flushed 
through the tube with plenty of rinsing [42, 
63]. 
Occupational exposure 
 Contact with drug particles by direct 
handling or aerosolisation during 
dose form modification. 
 Risk of exposure to toxic medications by 
staff. 
 Reports of infertility, abortion, and stillbirth 
in females handling chemotherapeutics 
[64, 65], hypersensitivities to antibiotics, 
contact dermatitis to chlorpromazine [49]. 
Legal implications 
 Modification of original dosage form 
leads to ‘off-label’ use unless 
explicitly identified by manufacturer 
directions. 
 Prescriber and/or person administering the 
medication is responsible for adverse 
events [42, 66]. 
 
6 Administering modified solid oral dosage forms 
After the solid oral dosage form is modified, the powdered tablets, or capsule 
contents may be mixed with food or fluid to help make the medicine easier to 
administer and swallow. A spoonful of food such as yoghurt, jam, custard, honey, 
apple sauce, pudding, and drinks such as fruit juices, are often used as vehicles for 
medicine delivery. Powdered medication may also be sprinkled across an entire 
meal [47-50], problems of which have already been introduced in Table 3. Regular 
use of sticky, highly sugared products that adhere to the mouth (e.g. honey or jam) 
should be avoided, especially for those with dysphagia for whom strict oral care is 
particularly important. Strict oral care reduces development of caries and 
proliferation of pathogenic oral bacteria that is a contributing factor to the 
development of aspiration pneumonia [41].  
Generally, crushing conventional immediate release tablets or opening capsules and 
mixing the contents with a small quantity e.g. one or two tablespoons of food seems 
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to have a comparatively small and insignificant effect on drug dissolution or 
absorption from crushed tablets [67-71]. However, the potential for impairment and 
variation in bioavailability should not be discounted. For instance, mixing crushed 
phenytoin tablets with pudding impaired absorption compared to apple sauce [72], 
and mixing enteric-coated beads of didanosine with yoghurt or apple sauce delayed 
absorption [73]. Food-drug interactions also need to be considered e.g. acidic foods 
such as pureed fruit can interfere with medication stability, and grapefruit, apples and 
oranges can affect the pharmacokinetic profile, and therefore pharmacodynamic 
outcomes of some drugs. Similarly, yoghurt and pudding containing milk products 
should not be used to administer medicines interacting with dairy products or calcium 
[49].  
6.1 Mixing with thickened fluids 
Patients with dysphagia have the texture of their food and liquids modified to reduce 
choking risk. The viscosity of liquids is increased using thickeners to slow liquid flow, 
allowing better control of the swallowing process to reduce aspiration risk [43, 74-
76]. The liquids are thickened to varying degrees according to dysphagia severity 
[77], and may be used as the vehicle for powdered medication delivery. 
In vitro testing in simulated gastric environments showed thickening agents could 
significantly impair the release of conventional tablets that were crushed. For 
example, crushed tablets of warfarin and carbamazepine showed only 14% 
dissolution after 30 minutes when mixed with a spoonful of thickened water [71]. 
Similar restrictions on drug dissolution were observed when elixirs or suspensions 
were mixed with thickeners [59]. The microstructure of the thickening agents 
appeared to trap the crushed medicine impeding their release; and the thicker the 
liquid the more impaired the release [78]. In addition, the ionic charge on a 
commonly used thickening agent (xanthan gum) theoretically may further complicate 
drug release [79].  
Preliminary in vivo testing with crushed paracetamol and water thickened with 
xanthan gum, suggested that changes with drug absorption was unlikely to be 
clinically significant [6]. Shear forces exerted during swallowing may be expected to 
break up the thickened fluid globules, reducing droplet size and increasing drug 
release [78], and this is likely to be an important reason for differences between in 
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vitro and in vivo testing. However, the potential for a clinically significant effect of a 
polysaccharide gum-based thickener on a medication with a narrow therapeutic 
index should not be understated, particularly considering absorption of whole 
digoxin, penicillin and metformin tablets may be reduced when consumed with guar 
gum as a source of dietary fibre [80, 81]. 
6.2 Inconsistent practices  
Unidentified, or inconsistent approaches to dosage form modification may make it 
more difficult for clinicians to stabilise patients on medication regimens. This is 
particularly relevant if more than one person is likely to be responsible for drug 
preparation and administration e.g. hospitals, aged care facilities and group homes 
[82]. Additionally, older people are particularly vulnerable during transition between 
care settings, and are at an increased risk of experiencing adverse outcomes or 
medication misadventure due to miscommunication between healthcare providers 
[83].  
6.3 The healthcare team and work environment 
Gathering information about a patient’s ability to swallow solid oral dosage forms, 
and dosage form modification practices is not always a priority for healthcare 
professionals [84]. It has become an ‘orphan task’ as the issue does not clearly fall 
within the defined roles and responsibilities of any one healthcare professional per 
se. Patients are unlikely to offer information about their ability to swallow, or 
difficulties managing solid oral dosage forms, unless they are specifically asked [84-
86]. On the occasions where information is gathered about a patient’s swallowing 
ability, and dosage form modification practices, this information tends not to be easily 
located, non-standardised terminology is used, and there is no single consistent 
place to source this information.  
Workplace culture and governance structures will also influence how healthcare 
professionals manage patients who experience difficulty swallowing solid oral 
dosage forms e.g. availability and accessibility of relevant resources, and 
communication and continuity of care in transfer of information between healthcare 
professionals [82, 84]. For instance, validated bedside screening tools and referral 
pathways specific for swallowing difficulties of solid oral medicines do not currently 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
15 
 
exist for healthcare professionals. Similarly, nurses self-report regularly discussing 
medication dosage form modification with other healthcare professionals, which may 
be related to their roles being at the forefront of administering medicines to patients 
[84], However, there are also reports of nurses performing dosage form 
modifications without checking with the prescriber, leading to situations where 
modification was unnecessary, or where more suitable alternate forms of the 
medications were available [10, 45, 87]. 
Healthcare professionals will most likely advise a patient reporting difficulty with 
swallowing a non-modified-release, non-coated tablet, to modify their medication 
dosage form [84]. Worryingly, a small number of healthcare professionals would 
advise patients to modify or split a modified-release or coated solid oral dosage form 
[84], and some nurses or carers modify these types of medications before 
administration to their patients [43]. For the most part, healthcare professionals are 
concerned with modifying dosage forms with modified release properties or coatings, 
but only where there was a suffix attached to the product name to indicate this 
characteristic. However, since the suffix of medications can be omitted from 
prescriptions [88], this can inadvertently lead to dosage forms being inappropriately 
modified [53].  
6.4 Patient understanding of dosage form modification and health literacy 
Patients are reluctant to ask healthcare professionals for advice about difficulties 
with swallowing their medications and whether to modify solid medication dosage 
forms [4, 13, 22, 84, 89]. There are misconceptions that swallowing difficulties is an 
inevitable part of aging [22], others find it embarrassing, or do not think healthcare 
professionals can help [4]. Instead, many people take advice from friends and family 
or decide on their own to modify their medications [13], and where there is low 
individual health literacy, then incorrect or misleading information gets shared. 
Patients recognise there are “issues with modifying medication dosage forms” [4, 
13], i.e. that the medication would be ‘affected’, but could not provide reasoning or 
further details. They were most concerned about the taste of the medication, and 
issues around inconvenience and cleanliness, but were less informed about other 
effects [13].  
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Low levels of individual health literacy is associated with poor management of 
chronic conditions such as persistent pain, cardiovascular disease, respiratory 
disease; and poor participation in healthcare processes [90]. For example, 
medication labels affixed to medication boxes or bottles provide patients with 
instructions about how to take the medicines as prescribed. This often includes 
ancillary cautionary and advisory labels which are intended as an adjunct to the 
information pharmacists provide when dispensing medicines [49]. These labels can 
include warnings about special handling instructions as unintended exposure e.g. 
dosage form modifications, can cause harm to the patient and/or their carer. There 
may also be additional instructions alerting patients about appropriate use of 
medicines, which may include swallowing the dosage form whole, without crushing 
or chewing [49]. Unfortunately, many patients misunderstand and misinterpret these 
instructions [91, 92], or they may not even notice the affixed ancillary cautionary and 
advisory labels [93].  
7 Avoiding inappropriate dosage form modification practices, and improving 
medication administration to older people 
Issues associated with dosage form modification, and administering solid oral 
dosage forms to people who cannot swallow them is multifaceted. Where dosage 
form modification is unavoidable and necessary, reducing the risk of harm is the 
focus. An integrated and collaborative approach will help overcome some of these 
issues. This needs to start at dosage form design, to practices around preparation 
and administration of modified dosage forms and effective communication amongst 
interdisciplinary teams, and increasing patient awareness of issues with dosage form 
modification and swallowing difficulties. 
7.1 Dosage form design 
Manufacturers are advised to consider patient acceptability with regards to the size 
of oral medicines when designing and producing commercial solid oral dosage forms 
[94]. The United States Food and Drug Administration provide guidance on tablet 
size, shape and texture/coatings, weight, surface area, disintegration time and 
propensity for swelling, for generic oral solid dosage forms to help improve 
swallowability, which would be relevant for all drug manufacturers [95]. A solid oral 
dosage form which is the size of a cashew nut or almond should be re-considered for 
its appropriateness to be swallowed whole (Figure 1). Formulations that allow 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
17 
 
dispersion of the medication in food or liquid prior to swallowing e.g. capsules 
containing enteric coated beads or pellets for proton pump inhibitors are a good 
solution for many people with swallowing difficulties, but can be comparatively more 
costly to manufacture. Orally disintegrating/dispersing tablets and mini-tablets are 
two approaches with potential for large scale use. For example, mini-tablets (tablets 
that have a maximum 3 mm diameter) can be produced on conventional tablet 
presses [96]. Orally dispersing tablets or films can use relatively simple equipment, 
and as printing technologies develop at a fast pace the cost of production will come 
down [97].  
Alternatively, targeting alternative routes of administration would relieve the burden 
of oral delivery, e.g. nasal, pulmonary, and transdermal routes, though age-related 
differences in physiology must be considered during the design and testing phases 
[98]. However, development and widespread application of alternative, more patient-
friendly dosage forms are a longer term solution to a problem that needs to be 
addressed now. Therefore the focus also needs to be on immediate changes that 
can be made to help older people to take their oral solid dosage forms, and reduce 
the risks associated with dosage form modifications. 
7.2 The interdisciplinary team and practices around dosage form modification 
It is imperative that healthcare professionals are more assertive in deliberately 
considering a patient’s ability to swallow when prescribing, dispensing, or 
administering medicines. Initiating these conversations is as simple as asking ‘Do 
you ever have trouble swallowing tablets?’ together with ‘Do you ever cut or crush 
your medicine?’. Clinicians can take the answer into consideration when making 
clinical decisions with the patient, who are then more likely to receive appropriate 
advice on how to swallow or modify their medication dosage forms. 
Unfortunately, the answer to “who” of the healthcare professionals should assume 
this orphan task is still unclear, and will largely depend on the structure and 
functioning of the interdisciplinary team, and the care setting. A recent 
multidisciplinary study in geriatric hospital units reported a positive impact on the 
number of medicines crushed, and the number of patients receiving crushed 
medicines, when patient swallowing ability and dosage form modification practices 
were collected as part of routine admission and medication history information 
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gathering [99]. This collected information must then be documented using 
standardised terminology in an accessible location that all healthcare professionals 
will and can consistently access. In another study, a study of two Canadian care 
facilities found records of dysphagia were inconsistently included in multiple 
locations e.g. at the pharmacy, medication administration records and nursing care 
plan. However, nurses only responded consistently to the medication administration 
record, so work processes in the facility were changed so the speech pathologists 
used consistent terminology, and documented recommendations into the medication 
administration record for nurses and doctor’s orders, and ‘dysphagia alerts’ were 
introduced to pharmacy software [82]. This change positively impacted upon 
reducing inappropriate prescribing, dispensing and administration of medicines to 
people with dysphagia [82]. 
Encouraging information flow, and having ready access to relevant expertise 
knowledge and resources will reduce the risk of inappropriate dosage form 
modification practices. Workflow processes will need to be changed in order to 
deliberately and consistently discourage inappropriate dosage form modifications. 
For example, medicines that must not be crushed should be packaged separately 
from those that can be crushed. Creation of standard operating procedures and 
provision of staff training may  help to facilitate consistency in relation to practices 
such as dosage form modification, and administration of medicines to people with 
swallowing difficulties. Development of validated and convenient bedside screening 
tools and referral pathways specific for swallowing difficulties of solid oral medicines 
would help healthcare professionals to quickly, easily, and reliably determine if a 
patient is truly experiencing dysphagia. These can be helpful for determining if 
patients simply have difficulty swallowing solid-oral dosage forms, or if they require 
further referrals to another member of the interdisciplinary team e.g. speech 
pathologist for investigations.  
Effective interdisciplinary teams with shared-understanding of the roles, 
responsibilities and expertise of the other members of the team improve patient 
health outcomes [100, 101]. Best practice also looks for continuity of care, and 
including patient and/or carers as active participants in the clinical decision-making 
process to tailor care to patient needs e.g. considerations around ability to swallow 
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solid dosage forms. Speech pathologists (sometimes known as speech and 
language therapists) are skilled in the education of swallowing, particularly those 
who specialise in working with children or older people. However, given prescribers, 
pharmacists and nurses are directly involved in medication provision, they are ideally 
positioned to provide information on improving medication swallowing techniques for 
people who dislike or have an aversion to swallowing solid oral dosage forms. As 
such, targeting education towards these healthcare professionals regarding 
swallowing techniques for solid oral dosage forms may be most efficient. 
7.3 Strategies for helping people to swallow solid oral dosage forms whole, without 
chewing 
For people without dysphagia, it is possible to learn to swallow solid oral medications 
whole. Most of the resources focus on teaching pill-swallowing to children and 
adolescents, including those with autism or developmental delays [102], because by 
this age it is too expensive, inconvenient or impractical to give large volumes of 
paediatric liquid formulations. It is also possible for older adults to change their habits 
and learn to swallow medications whole.  
Given the oral cavity can detect something as fine as a human hair (0.075 mm or 75 
microns), strategies need to facilitate solid oral dosage forms to be swallowed 
without being detected and ejected. The essential element of learning to swallow 
medications involves ‘hiding’ the solid dosage form from the highly sensitive oral 
sensory receptors, and three broad strategies can be used (Table 4). 
Table 4. Strategies used by speech pathologists to teach people how to swallow solid dose 
forms whole without chewing. 
Strategy Action Outcome Comment 
Disguise as 
smooth bolus 
Place inside typical 
food item e.g. yoghurt, 
pudding, wrapped in 
small piece of bread 
Brain recognises it as ‘food’ 
as the oral receptors feel 
the smooth moist bolus and 
allow it to pass through the 
oral cavity for swallowing 
without chewing 
Food-drug 
interaction 
possible, so this 
is not the 
preferred option 
Disguise as 
water bolus 
Place on tongue 
towards the front of 
the mouth. Take a 
mouthful of liquid, and 
swallow just as the 
solid dose form begins 
to float. Follow quickly 
with 2-3 swallows of 
Oral receptors detect the 
water bolus, and cannot 
recognise the solid dosage 
form being swallowed. The 
water moves through the 
mouth at sufficient velocity, 
like a surfer being caught in 
a wave, so the solid dosage 
Requires 
practise 
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water. form is submerged in the 
water and hidden from the 
sensory receptors. 
Systematic 
desensitisation 
Start with swallowing 
whole something very 
small and gradually 
increase the size. E.g. 
start with a small 
piece of a jelly candy, 
for example one-third 
of a Jelly Baby. When 
this is managed 
without difficulty, 
gradually increase 
until the size of a 
medication is reached.  
Desensitise the oral 
receptors to the urge to 
chew 
Use in 
combination 
with water 
bolus 
 
When swallowing solid dosage forms, postural adjustments can also facilitate a safe 
swallow. The head should be kept in either a neutral position or with the chin tipped 
down towards the chest [103]. Flicking the head back opens the airway in much the 
same way that a ‘head back’ position (Figure 2) opens the airway for pulmonary 
resuscitation, and provides the solid dose with a direct trajectory to the lungs. Thus, 
although some people may think a head back position helps to swallow whole tablets 
[103], it should be avoided. People who tip or flick their heads back are attempting to 
‘hide’ the solid dose from the oral sensory receptors by making it ‘fly’ through the oral 
cavity, avoiding the sensory receptors to take the dose directly to the back of the 
mouth where the swallow reflex is initiated. 
Products marketed for helping people swallow medications whole are easily 
accessible, especially via the internet. Lubricating the passage of the medication 
through the oropharyngeal tract can improve the medication swallowing experience. 
Examples of commercial products include those that apply a coating (e.g. Medcoat 
[104, 105]) or gel (e.g. Gloup) to the medication, or a spray applied to the tongue and 
oral mucosal membranes (e.g. Pill Glide [106, 107]). There are also cups and straws 
that suspend the medication above the drink so it is carried into the mouth together 
with the liquid in much the same way as disguising the solid dosage form in a water 
bolus (Table 4). However, the effectiveness of most of these devices have not been 
independently established, and comparisons have not been made between them.  
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7.4 Increasing awareness of issues and patient health literacy 
Assertive information gathering by healthcare professionals will help begin to 
increase patient awareness of the risks associated with dosage form modification 
and challenges administering medicines to older people. A simultaneous approach to 
improving patient health literacy, from both an individual patient, and a health 
environment perspective is required [90]. Health literacy is more than just language 
literacy, and includes considerations around patient skills, knowledge, and motivation 
to make effective decisions about their health. Similarly, the health literacy 
environment includes infrastructure, policies, processes etc. which make up the 
health system, and how that impacts upon the way patients engage or navigate with 
the health services. Therefore, healthcare professionals must also consider a 
patient’s health literacy when prescribing, dispensing, administering, and providing 
information about medicines to older patients and/or their carers. 
8 Conclusion 
Swallowing a solid dosage form is a learned skill, requiring people to override their 
natural instincts to chew solid objects. Older people commonly experience 
swallowing difficulties because of aged-related physiological changes, co-
morbidities, and polypharmacy. The strategy healthcare professionals and patients 
often use to make medicines easier to swallow, is to modify the dosage form. An 
integrated and collaborative approach is needed to reduce inappropriate dosage 
form modifications, and improve medication administration to older people. This 
needs to start from the point of dosage form design, to what medication is prescribed 
and dispensed, and how it is administered to/by the patient. Promising opportunities 
exist with novel dosage form designs that can bypass the need for solid oral dosage 
forms. However, until these delivery devices become more readily available, 
affordable and accessible, integrated approaches to improve healthcare professional 
awareness, work processes, and patient health literacy would contribute significantly 
to reducing the practice of inappropriate dosage form modification. 
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11 Figure captions 
Figure 1. The relative size of a coin (US dime), cashew, a modified-release tablet, 
cashew nut, soft gelatine capsule, and almond. Each square is 5 mm x 5 mm. 
 
Figure 2. The head should be in a neutral position (A) or tipped forward (B) for safe 
swallowing of solid doses. Flicking the head back (C) opens the airway, providing a 
direct trajectory for the solid dose to the lungs. 
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